Disclosure of Financial Controls. In connection with the filing of Roivant’s annual and quarterly reports under the Exchange Act or any investigations of prior periods, the Company shall cause its principal executive officer and principal financial officer to provide to Roivant and its Representatives (A) on a timely basis, if this provision is applicable by virtue of Section 2.01(B)(ii)(x) and (B) on a timely basis and if reasonably requested by Roivant, if this provision is applicable by virtue of Sections 2.01(B)(i) or (ii)(y) or (z), (1) certifications to Roivant corresponding to those required under Sections 302 and 906 of the Xxxxxxxx-Xxxxx Act, (2) any certificate that may be reasonably necessary for Roivant to satisfy the requirements applicable to it under Section 404 of the Xxxxxxxx-Xxxxx Act, (3) any certificates or other written information that the Company’s principal executive officer or principal financial officer received as support for the certificates provided to Roivant and (4) a reasonable opportunity to discuss with the Company’s principal financial officer and other appropriate officers and employees of the Company any issues reasonably related to the foregoing.
Appears in 3 contracts
Samples: Sharing and Cooperation Agreement (Immunovant, Inc.), Sharing and Cooperation Agreement (Dermavant Sciences LTD), Sharing and Cooperation Agreement (Urovant Sciences Ltd.)
Disclosure of Financial Controls. In connection with the filing of Roivant’s annual and quarterly reports under the Exchange Act or any investigations of prior periods, the Company shall cause its principal executive officer and principal financial officer to provide to Roivant and its Representatives (A) on a timely basis, if this provision is applicable by virtue of Section 2.01(B)(ii)(x3.01(B)(ii)(x) and (B) on a timely basis and if reasonably requested by Roivant, if this provision is applicable by virtue of Sections 2.01(B)(i3.01(B)(i) or (ii)(y) or (z), (1) certifications to Roivant corresponding to those required under Sections 302 and 906 of the Xxxxxxxx-Xxxxx Act, (2) any certificate that may be reasonably necessary for Roivant to satisfy the requirements applicable to it under Section 404 of the Xxxxxxxx-Xxxxx Act, (3) any certificates or other written information that the Company’s principal executive officer or principal financial officer received as support for the certificates provided to Roivant and (4) a reasonable opportunity to discuss with the Company’s principal financial officer and other appropriate officers and employees of the Company any issues reasonably related to the foregoing.
Appears in 1 contract
Samples: Sharing and Cooperation Agreement (Axovant Sciences Ltd.)
Disclosure of Financial Controls. In connection with the filing of RoivantSumitovant’s annual and quarterly reports under the Exchange Act or any investigations of prior periods, the Company shall cause its principal executive officer and principal financial officer to provide to Roivant Sumitovant and its Representatives (A) on a timely basis, if this provision is applicable by virtue of Section Section 2.01(B)(ii)(x) and (B) on a timely basis and if reasonably requested by RoivantSumitovant, if this provision is applicable by virtue of Sections 2.01(B)(i2.01(B)(i) or (ii)(y) or (z), (1) certifications to Roivant Sumitovant corresponding to those required under Sections 302 and 906 of the XxxxxxxxSxxxxxxx-Xxxxx Act, (2) any certificate that may be reasonably necessary for Roivant Sumitovant to satisfy the requirements applicable to it under Section 404 of the XxxxxxxxSxxxxxxx-Xxxxx Act, (3) any certificates or other written information that the Company’s principal executive officer or principal financial officer received as support for the certificates provided to Roivant Sumitovant and (4) a reasonable opportunity to discuss with the Company’s principal financial officer and other appropriate officers and employees of the Company any issues reasonably related to the foregoing.
Appears in 1 contract
Samples: Sharing and Cooperation Agreement (Urovant Sciences Ltd.)